191 related articles for article (PubMed ID: 11483215)
1. A solid-phase competition ELISA for measuring antibody to foot-and-mouth disease virus.
Mackay DK; Bulut AN; Rendle T; Davidson F; Ferris NP
J Virol Methods; 2001 Sep; 97(1-2):33-48. PubMed ID: 11483215
[TBL] [Abstract][Full Text] [Related]
2. Validation of a foot-and-mouth disease antibody screening solid-phase competition ELISA (SPCE).
Paiba GA; Anderson J; Paton DJ; Soldan AW; Alexandersen S; Corteyn M; Wilsden G; Hamblin P; MacKay DK; Donaldson AI
J Virol Methods; 2004 Feb; 115(2):145-58. PubMed ID: 14667530
[TBL] [Abstract][Full Text] [Related]
3. Development and Validation of Confirmatory Foot-and-Mouth Disease Virus Antibody ELISAs to Identify Infected Animals in Vaccinated Populations.
Tewari A; Ambrose H; Parekh K; Inoue T; Guitian J; Nardo AD; Paton DJ; Parida S
Viruses; 2021 May; 13(5):. PubMed ID: 34063385
[TBL] [Abstract][Full Text] [Related]
4. An overview on ELISA techniques for FMD.
Ma LN; Zhang J; Chen HT; Zhou JH; Ding YZ; Liu YS
Virol J; 2011 Sep; 8():419. PubMed ID: 21888667
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic application of recombinant non-structural protein 3A to detect antibodies induced by foot-and-mouth disease virus infection.
Biswal JK; Ranjan R; Pattnaik B
Biologicals; 2016 May; 44(3):157-62. PubMed ID: 26995490
[TBL] [Abstract][Full Text] [Related]
6. Anti-3AB antibodies in the Chinese yellow cattle infected by the O/Taiwan/99 foot-and-mouth disease virus.
Huang CC; Lee F; Tu WJ; Lee SH; Huang TS; Lin YL; Jong MH; Lin SY
Vet Microbiol; 2002 Feb; 84(4):317-26. PubMed ID: 11750140
[TBL] [Abstract][Full Text] [Related]
7. Validation of an r3AB1-FMDV-NSP ELISA to distinguish between cattle infected and vaccinated with foot-and-mouth disease virus.
Jaworski JP; Compaired D; Trotta M; Perez M; Trono K; Fondevila N
J Virol Methods; 2011 Dec; 178(1-2):191-200. PubMed ID: 21946290
[TBL] [Abstract][Full Text] [Related]
8. Recombinant non-structural polyprotein 3AB-based serodiagnostic strategy for FMD surveillance in bovines irrespective of vaccination.
Mohapatra JK; Pandey LK; Sanyal A; Pattnaik B
J Virol Methods; 2011 Nov; 177(2):184-92. PubMed ID: 21864578
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a 3ABC indirect ELISA for differentiation of foot-and-mouth disease virus infected from vaccinated animals.
Lu Z; Cao Y; Guo J; Qi S; Li D; Zhang Q; Ma J; Chang H; Liu Z; Liu X; Xie Q
Vet Microbiol; 2007 Nov; 125(1-2):157-69. PubMed ID: 17601688
[TBL] [Abstract][Full Text] [Related]
10. Development and Validation of a Mucosal Antibody (IgA) Test to Identify Persistent Infection with Foot-and-Mouth Disease Virus.
Biswal JK; Nardo AD; Taylor G; Paton DJ; Parida S
Viruses; 2021 May; 13(5):. PubMed ID: 34062811
[TBL] [Abstract][Full Text] [Related]
11. Detection of antibodies against foot-and-mouth disease virus using a liquid-phase blocking sandwich ELISA (LPBE) with a bioengineered 3D protein.
O'Donnell VK; Boyle DB; Sproat K; Fondevila NA; Forman A; Schudel AA; Smitsaart EN
J Vet Diagn Invest; 1996 Apr; 8(2):143-50. PubMed ID: 8744733
[TBL] [Abstract][Full Text] [Related]
12. Specificity of non-structural protein enzyme-linked immunosorbent assays for the detection of serum antibodies against foot-and-mouth disease virus in a target population in New Zealand.
Kittelberger R; Mackereth GF; Sewell M; Keall J; Clough R; Pigott C; O'Keefe JS
N Z Vet J; 2008 Oct; 56(5):227-32. PubMed ID: 18836503
[TBL] [Abstract][Full Text] [Related]
13. The longevity of anti NSP antibodies and the sensitivity of a 3ABC ELISA - A 3 years follow up of repeatedly vaccinated dairy cattle infected by foot and mouth disease virus.
Elnekave E; Shilo H; Gelman B; Klement E
Vet Microbiol; 2015 Jul; 178(1-2):14-8. PubMed ID: 25937314
[TBL] [Abstract][Full Text] [Related]
14. Comparative evaluation of three commercial ELISA kits for detection of antibodies to a nonstructural protein of foot-and-mouth disease virus.
Fukai K; Morioka K; Onozato H; Yoshida K; Sakamoto K
J Vet Med Sci; 2013; 75(6):693-9. PubMed ID: 23328606
[TBL] [Abstract][Full Text] [Related]
15. Differentiating infection from vaccination in foot-and-mouth-disease: evaluation of an ELISA based on recombinant 3ABC.
Bruderer U; Swam H; Haas B; Visser N; Brocchi E; Grazioli S; Esterhuysen JJ; Vosloo W; Forsyth M; Aggarwal N; Cox S; Armstrong R; Anderson J
Vet Microbiol; 2004 Jul; 101(3):187-97. PubMed ID: 15223123
[TBL] [Abstract][Full Text] [Related]
16. Cedivac-FMD can be used according to a marker vaccine principle.
Chénard G; Selman P; Dekker A
Vet Microbiol; 2008 Apr; 128(1-2):65-71. PubMed ID: 18035508
[TBL] [Abstract][Full Text] [Related]
17. Quantitative single dilution liquid phase blocking ELISA for sero-monitoring of foot-and-mouth disease in India.
Sharma GK; Mahajan S; Matura R; Subramaniam S; Mohapatra JK; Pattnaik B
Biologicals; 2015 May; 43(3):158-64. PubMed ID: 25911541
[TBL] [Abstract][Full Text] [Related]
18. An ELISA based on the repeated foot-and-mouth disease virus 3B epitope peptide can distinguish infected and vaccinated cattle.
Gao M; Zhang R; Li M; Li S; Cao Y; Ma B; Wang J
Appl Microbiol Biotechnol; 2012 Feb; 93(3):1271-9. PubMed ID: 22207215
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a solid-phase competition ELISA based on virus-like particles of foot-and-mouth disease virus serotype A for antibody detection.
Zhang Y; Yan H; Yao Y; Zhang S; Xiao Y; Xu X; Huang B; Tian K
Arch Virol; 2020 Jul; 165(7):1641-1646. PubMed ID: 32350612
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody based solid phase competition ELISA to detect FMDV serotype A specific antibodies.
Hema Sayee R; Hosamani M; Krishnaswamy N; Shanmuganathan S; Nagasupreeta SR; Sri Sai Charan M; Sheshagiri G; Gairola V; Basagoudanavar SH; Sreenivasa BP; Bhanuprakash V
J Virol Methods; 2024 Jul; 328():114959. PubMed ID: 38788979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
